International Biotechnology Trust PLCLSE: IBT

International Biotechnology Trust: Net Asset Value(s)

· Issued by International Biotechnology Trust PLC via RNS

Summary by 6ix AI

International Biotechnology Trust plc reported its unaudited net asset value (NAV, the value of its assets minus its liabilities) per share as of Tuesday, November 10: 1154.90 pence excluding income and 1113.60 pence including income.

Key details

  • The ex income figure leaves out current income, while the cum income figure includes it.
  • The company says the figures were calculated in line with the recommendations of the Association of Investment Companies.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/net-asset-values-24095

Watch International Biotechnology Trust's latest callInternational Biotechnology Trust (LSE:IBT) — Investor Presentation · Replay · Nov 3
Intl. Biotechnology Trust PLC
11 November 2026
International Biotechnology Trust plc
Net Asset Values
The Board of International Biotechnology Trust PLC (the "Company") announces the unaudited net asset value ("NAV") per share of the Company as follows:
DateNAVPence
Tuesday 10 NovEx Income1154.90
Tuesday 10 NovCum Income1113.60
The above NAVs have been calculated in accordance with the recommendations of the Association of Investment Companies.
11-Nov-2026
Enquiries:
International Biotechnology Trust plc
Schroder Investment Management Limited
Company Secretary 0207 658 6501

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

International Biotechnology Trust PLC on 6ix

Earlier from International Biotechnology Trust

All International Biotechnology Trust news releases